awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37903703-0284F95C-EF8E-4142-9888-0BB957EFB321
Q37903703-0284F95C-EF8E-4142-9888-0BB957EFB321
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37903703-0284F95C-EF8E-4142-9888-0BB957EFB321
Systematic review of pharmacogenetic testing for predicting clinical benefit to anti-EGFR therapy in metastatic colorectal cancer.
P2860
Q37903703-0284F95C-EF8E-4142-9888-0BB957EFB321
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37903703-0284F95C-EF8E-4142-9888-0BB957EFB321
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af3dc9c28614420008427e648c158013028be18c
P2860
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.